hemophilia a and b, new phase ii data confirming fitusiran and rna interference technology
Published 5 years ago • 280 plays • Length 3:31Download video MP4
Download video MP3
Similar videos
-
3:31
fitusiran and hemophilia: early data very promising
-
23:49
the future of nonfactor therapies in hemophilia a and b: the art and science of rna interference
-
2:04
alnylam pipeline: fitusiran and inclisiran
-
7:56
guy young: fitusiran for hemophilia a and b with inhibitors
-
3:23
new approaches to hemophilia research
-
3:03
insights into the mechanism of action of fitusiran & the value of this agent in hemophilia treatment
-
3:04
fitusiran significantly reduces bleeding events in patients with hemophilia a or b, with inhibitors
-
7:13
hemophilia a vs hemophilia b | genetics, symptoms and treatment
-
1:34
understanding hemophilia
-
24:47
a fitusiran clinical trial update and nikole scappe co-wrote a book!
-
2:12
improving outcomes in hemophilia a
-
0:44
current aav hemophilia b gene therapy trials
-
3:03
diagnosis in haemophilia | haemnet | creative connection
-
2:28
unveiling hemophilia a | episode 2: introducing inhibitors.
-
11:26
alnylam’s phase 3 clinical trials with givosiran
-
2:18
personalized fviii treatment for hemophilia a | bayer
-
1:48
hemophilia study companion - case 2
-
9:36
hemophilia (year of the zebra)
-
58:33
webinar: evidence based guideline in hemophilia care a model for rare disease guidelines